Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ewgenij Proschak

Showing results (81-90 of 183) with videos related to

Pageof 19
Sort By:
ACS Infectious Diseases|February 28, 2018
Binding Mode Characterization and Early in Vivo Evaluation of Fragment-Like Thiols as Inhibitors of the Virulence Factor LasB from Pseudomonas aeruginosaAndreas M Kany, Asfandyar Sikandar, Jörg Haupenthal, et al.
Bioorganic & Medicinal Chemistry Letters|October 12, 2014
Vanillin-derived antiproliferative compounds influence Plk1 activityRoberto Carrasco-Gomez, Sarah Keppner-Witter, Martina Hieke, et al.
ACS Pharmacology & Translational Science|March 20, 2025
Fatty Acid Mimetic Fragments as Liver Receptor Homologue-1 ModulatorsAlisa Lang, Tanja Stiller, Niklas Ildefeld, et al.
Chemmedchem|December 6, 2008
From molecular shape to potent bioactive agents I: bioisosteric replacement of molecular fragmentsEwgenij Proschak, Heiko Zettl, Yusuf Tanrikulu, et al.
European Journal of Medicinal Chemistry|November 3, 2019
Soluble epoxide hydrolase inhibitors with carboranes as non-natural 3-D pharmacophoresMatthias S Scholz, Lukas M Wingen, Steffen Brunst, et al.
Chembiochem : a European Journal of Chemical Biology|September 27, 2007
Scaffold hopping by "fuzzy" pharmacophores and its application to RNA targetsYusuf Tanrikulu, Manuel Nietert, Ute Scheffer, et al.
Scientific Reports|May 3, 2018
Allosteric modulation of the farnesoid X receptor by a small moleculeMatthias Gabler, Jan Kramer, Jurema Schmidt, et al.
Chemmedchem|December 6, 2008
From molecular shape to potent bioactive agents II: fragment-based de novo designEwgenij Proschak, Kerstin Sander, Heiko Zettl, et al.
Bioorganic & Medicinal Chemistry|September 24, 2009
2,4-Diaminopyrimidines as histamine H4 receptor ligands--Scaffold optimization and pharmacological characterizationKerstin Sander, Tim Kottke, Yusuf Tanrikulu, et al.
Drug Discovery Today|June 28, 2025
Rediscovering nitroxoline: a metal-chelating agent bridging infection and cancerPraveen Papareddy, Sophie R M Mielke, Marlowe Graham, et al.
Pageof 19

Showing results (81-90 of 183) with videos related to

Sort By:
Pageof 19
ACS Infectious Diseases|February 28, 2018
Binding Mode Characterization and Early in Vivo Evaluation of Fragment-Like Thiols as Inhibitors of the Virulence Factor LasB from Pseudomonas aeruginosaAndreas M Kany, Asfandyar Sikandar, Jörg Haupenthal, et al.
Bioorganic & Medicinal Chemistry Letters|October 12, 2014
Vanillin-derived antiproliferative compounds influence Plk1 activityRoberto Carrasco-Gomez, Sarah Keppner-Witter, Martina Hieke, et al.
ACS Pharmacology & Translational Science|March 20, 2025
Fatty Acid Mimetic Fragments as Liver Receptor Homologue-1 ModulatorsAlisa Lang, Tanja Stiller, Niklas Ildefeld, et al.
Chemmedchem|December 6, 2008
From molecular shape to potent bioactive agents I: bioisosteric replacement of molecular fragmentsEwgenij Proschak, Heiko Zettl, Yusuf Tanrikulu, et al.
European Journal of Medicinal Chemistry|November 3, 2019
Soluble epoxide hydrolase inhibitors with carboranes as non-natural 3-D pharmacophoresMatthias S Scholz, Lukas M Wingen, Steffen Brunst, et al.
Chembiochem : a European Journal of Chemical Biology|September 27, 2007
Scaffold hopping by "fuzzy" pharmacophores and its application to RNA targetsYusuf Tanrikulu, Manuel Nietert, Ute Scheffer, et al.
Scientific Reports|May 3, 2018
Allosteric modulation of the farnesoid X receptor by a small moleculeMatthias Gabler, Jan Kramer, Jurema Schmidt, et al.
Chemmedchem|December 6, 2008
From molecular shape to potent bioactive agents II: fragment-based de novo designEwgenij Proschak, Kerstin Sander, Heiko Zettl, et al.
Bioorganic & Medicinal Chemistry|September 24, 2009
2,4-Diaminopyrimidines as histamine H4 receptor ligands--Scaffold optimization and pharmacological characterizationKerstin Sander, Tim Kottke, Yusuf Tanrikulu, et al.
Drug Discovery Today|June 28, 2025
Rediscovering nitroxoline: a metal-chelating agent bridging infection and cancerPraveen Papareddy, Sophie R M Mielke, Marlowe Graham, et al.
Pageof 19